Elisabetta Fenocchio Selected Research

Elisabetta Fenocchio Research Topics

16	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2019
11	Neoplasms (Cancer) 01/2023 - 01/2018
6	Microsatellite Instability 01/2023 - 01/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 10/2016
3	Disease Progression 12/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 06/2023 - 01/2022
2	Inflammation (Inflammations) 06/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 03/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 01/2018
2	Cholangiocarcinoma 01/2021 - 11/2020
1	Adenocarcinoma 11/2023
1	Cardiotoxicity 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2022
1	Ascites 01/2022
1	Frailty 01/2022
1	Melanoma (Melanoma, Malignant) 07/2021
1	Adenocarcinoma of Lung 07/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Hamman-Rich Syndrome (Hamman Rich Syndrome) 10/2016
1	Pneumonia (Pneumonitis) 10/2016
1	Respiratory Insufficiency (Respiratory Failure) 10/2016
1	Fibrosis (Cirrhosis) 10/2016

7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2021
2	trifluridine tipiracil drug combinationIBA 01/2023 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2019
2	Lapatinib (GW572016)FDA Link 12/2020 - 01/2020
2	pertuzumabIBA 12/2020 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2020
2	Gemcitabine FDA Link 01/2018 - 10/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2023
1	AutoantibodiesIBA 11/2023
1	Carrier Proteins (Binding Protein)IBA 11/2023
1	ElementsIBA 11/2023
1	RadiopharmaceuticalsIBA 06/2023
1	Codon (Codons)IBA 01/2023
1	Calcibiotic Root Canal SealerIBA 01/2023
1	Complement System Proteins (Complement)IBA 03/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Panitumumab (Vectibix)FDA Link 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	regorafenibIBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	SteroidsIBA 10/2016
1	Imatinib Mesylate (Gleevec)FDA Link 10/2016

10	Therapeutics 11/2023 - 10/2016
10	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
1	Immunotherapy 03/2022
1	Palliative Care (Palliative Therapy) 01/2020
1	Immunomodulation 01/2018